Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Towards an effective malaria vaccine

Pedro Aide1, Quique Bassat, Pedro L Alonso

  • 1National Institute of Health, Ministry of Health, Mozambique. palonso@clinic.ub.es

Archives of Disease in Childhood
|May 23, 2007
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation, coverage and impact of a programmatic mass drug administration campaign for malaria in southern Mozambique.

BMC public health·2026
Same author

Estimating probabilities of malaria importation in southern Mozambique through modelling <i>P. falciparum</i> genomics and mobility patterns.

eLife·2026
Same author

Bacillus Calmette-Guérin Vaccination and SARS-CoV-2 Infection among Healthcare Workers: A Case-Control Study in Cape Verde.

Portuguese journal of public health·2026
Same author

Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trial.

The Lancet. Infectious diseases·2026
Same author

Efficacy of artemether-lumefantrine for uncomplicated plasmodium falciparum malaria treatment in mozambique: a systematic review and meta-analysis.

Malaria journal·2026
Same author

Duration and association with protection of NANP-repeat-specific and C-terminus-specific anti-circumsporozoite protein IgG responses following RTS,S/AS01<sub>E</sub> vaccination: an observational ancillary immunological study of a phase 3 clinical trial.

The Lancet. Infectious diseases·2026